AI assistant
Sending…
TG THERAPEUTICS, INC. — Director's Dealing 2024
Feb 15, 2024
31066_dirs_2024-02-14_e4813003-808a-4352-8d5d-ba43b7be052f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: TG THERAPEUTICS, INC. (TGTX)
CIK: 0001001316
Period of Report: 2024-02-14
Reporting Person: Power Sean A (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-15 | Common Stock | G | 40000 | — | Disposed | 641969 | Direct |
Footnotes
F1: Reflects the transfer of shares of TG Therapeutics stock to the Power Family and Descendants Trust.
More from TG THERAPEUTICS, INC.
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 20
Annual Report
2026
Feb 27
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Jan 29
Regulatory Filings
2026
Jan 13
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2025
Nov 25
Regulatory Filings
2025
Nov 24